论文部分内容阅读
目的:探讨单纯子宫腺肌病与合并子宫肌瘤的子宫腺肌病进行子宫动脉栓塞治疗后5年疗效。方法:对2005年2月~2011年2月间在该院住院治疗的子宫腺肌病患者进行筛选得到180例。根据核磁共振检查结果分为单纯子宫腺肌病组(A组)118例,合并子宫肌瘤组(B组)62例。对比两组患者子宫动脉栓塞术前后痛经的分级变化情况。结果:术后1~5年的随访率78.33%(141/180)。术后3~5年有效率相对平稳。两组患者术后1~4年治疗有效率之间差异无统计学意义(P>0.05),术后第5年B组患者治疗有效率(79.03%)显著高于A组患者(57.63%),差异有统计学意义(P<0.05)。结论:子宫动脉栓塞术对于合并子宫肌瘤的子宫腺肌病患者具有较好的长期疗效,子宫动脉栓塞术前医师应依据患者具体情况选取不同直径的栓塞剂和手术方案。
Objective: To investigate the efficacy of uterine arterial embolization after simple adenomyosis and adenomyosis with uterine fibroids. Methods: From February 2005 to February 2011 in the hospital for treatment of adenomyosis patients were screened 180 cases. According to the results of MRI, there were 118 cases with simple adenomyosis group (group A) and 62 cases with uterine fibroid group (group B). The grade changes of dysmenorrhea before and after uterine artery embolization were compared between the two groups. Results: The follow-up rate of 1 to 5 years after operation was 78.33% (141/180). 3 to 5 years after the operation is relatively stable. There was no significant difference between the two groups (P> 0.05). The effective rate of treatment in group B (79.03%) was significantly higher than that in group A (57.63%) in the fifth year after operation , The difference was statistically significant (P <0.05). Conclusion: Uterine arterial embolization has a good long-term curative effect for patients with adenomyosis with uterine fibroids. The pre-uterine arterial embolization physicians should choose embolization agents and surgical plans of different diameters according to the specific conditions of patients.